371 related articles for article (PubMed ID: 36074324)
1. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
Ye K; Li L; Wu B; Wang D
Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
[TBL] [Abstract][Full Text] [Related]
2. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
Qian K; Xu W; Xia X; Ding J
Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
[TBL] [Abstract][Full Text] [Related]
3. METTL3 promotes choriocarcinoma progression by activating the miR-935/GJA1 pathway in an m6A-dependent manner.
Wang W; Shi J; Zheng L
Am J Reprod Immunol; 2023 Nov; 90(5):e13791. PubMed ID: 37881126
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
[TBL] [Abstract][Full Text] [Related]
5. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
Li S; Lu X; Zheng D; Chen W; Li Y; Li F
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
[TBL] [Abstract][Full Text] [Related]
6. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
Liu J; Jiang K
J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
Gong Y; Luo G; Zhang S; Chen Y; Hu Y
Cell Signal; 2024 May; 117():111068. PubMed ID: 38286198
[TBL] [Abstract][Full Text] [Related]
8. METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.
Huang G; Qiu Y; Fan Y; Liu J
Neurochem Res; 2024 Jan; 49(1):85-98. PubMed ID: 37610605
[TBL] [Abstract][Full Text] [Related]
9. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
[TBL] [Abstract][Full Text] [Related]
10. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.
Zhang QC
Kaohsiung J Med Sci; 2023 Mar; 39(3):266-277. PubMed ID: 36546578
[TBL] [Abstract][Full Text] [Related]
11. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox.
Zhou Y; Li W
Environ Toxicol; 2024 Mar; 39(3):1631-1640. PubMed ID: 38018881
[TBL] [Abstract][Full Text] [Related]
12. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
[TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
Huang Y; Guan Y; Zhang X
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37498409
[TBL] [Abstract][Full Text] [Related]
14. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
Zhang CP; Huang XY
Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
[TBL] [Abstract][Full Text] [Related]
16. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
[TBL] [Abstract][Full Text] [Related]
17. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
[TBL] [Abstract][Full Text] [Related]
18. METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.
Gong WJ; Li R; Dai QQ; Yu P
J Gastroenterol Hepatol; 2022 Dec; 37(12):2229-2242. PubMed ID: 36068012
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
Bao J; Xu T; Wang W; Xu H; Chen X; Xia R
Mol Cell Biochem; 2024 Jan; ():. PubMed ID: 38180718
[TBL] [Abstract][Full Text] [Related]
20. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
